Cargando…
Opportunities and Challenges of Using Big Data to Detect Drug‐Drug Interaction Risk
Autor principal: | Quinney, Sara K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617974/ https://www.ncbi.nlm.nih.gov/pubmed/31184772 http://dx.doi.org/10.1002/cpt.1481 |
Ejemplares similares
-
Big Biological Data: Challenges and Opportunities
por: Li, Yixue, et al.
Publicado: (2014) -
Clinical epidemiology in the era of big data: new opportunities, familiar challenges
por: Ehrenstein, Vera, et al.
Publicado: (2017) -
Model Informed Drug Development and Regulation in China: Challenges and Opportunities
por: Li, Li, et al.
Publicado: (2019) -
Challenges and opportunities for improving access to approved neonatal drugs and devices
por: Lewis, Tamorah, et al.
Publicado: (2022) -
Artificial Intelligence, Machine Learning, and Big Data for Ebola Virus Drug Discovery
por: Kwofie, Samuel K., et al.
Publicado: (2023)